PH27309A - Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones - Google Patents

Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones

Info

Publication number
PH27309A
PH27309A PH41540A PH41540A PH27309A PH 27309 A PH27309 A PH 27309A PH 41540 A PH41540 A PH 41540A PH 41540 A PH41540 A PH 41540A PH 27309 A PH27309 A PH 27309A
Authority
PH
Philippines
Prior art keywords
enveloped virus
ones
isoquinolyloxazone
quinolyl
glycoprotein
Prior art date
Application number
PH41540A
Other languages
English (en)
Inventor
Sai Prasad Sunkara
Winston D Jones
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Priority to PH41540A priority Critical patent/PH27309A/en
Publication of PH27309A publication Critical patent/PH27309A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH41540A 1989-11-13 1990-11-03 Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones PH27309A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH41540A PH27309A (en) 1989-11-13 1990-11-03 Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43531889A 1989-11-13 1989-11-13
PH41540A PH27309A (en) 1989-11-13 1990-11-03 Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones
PH6171591 1991-10-29

Publications (1)

Publication Number Publication Date
PH27309A true PH27309A (en) 1993-05-28

Family

ID=23727911

Family Applications (1)

Application Number Title Priority Date Filing Date
PH41540A PH27309A (en) 1989-11-13 1990-11-03 Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones

Country Status (11)

Country Link
EP (1) EP0428105B1 (fr)
JP (1) JP2927930B2 (fr)
KR (1) KR0162639B1 (fr)
AT (1) ATE100318T1 (fr)
AU (1) AU630249B2 (fr)
DE (1) DE69006187T2 (fr)
DK (1) DK0428105T3 (fr)
ES (1) ES2062266T3 (fr)
IE (1) IE63851B1 (fr)
PH (1) PH27309A (fr)
ZA (1) ZA908933B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107327A (en) * 1996-08-30 2000-08-22 Eli Lilly And Company Therapeutic treatment for HIV infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886811A (en) * 1988-10-24 1989-12-12 Merrell Dow Pharmaceuticals Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Also Published As

Publication number Publication date
KR0162639B1 (ko) 1998-12-01
JP2927930B2 (ja) 1999-07-28
IE63851B1 (en) 1995-06-14
DE69006187T2 (de) 1994-05-05
IE904079A1 (en) 1991-05-22
EP0428105A2 (fr) 1991-05-22
DK0428105T3 (da) 1994-02-28
ATE100318T1 (de) 1994-02-15
KR910009260A (ko) 1991-06-28
DE69006187D1 (de) 1994-03-03
AU630249B2 (en) 1992-10-22
EP0428105A3 (en) 1991-12-11
ZA908933B (en) 1991-08-28
JPH03173886A (ja) 1991-07-29
ES2062266T3 (es) 1994-12-16
EP0428105B1 (fr) 1994-01-19
AU6592990A (en) 1991-05-16

Similar Documents

Publication Publication Date Title
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
SG52628A1 (en) Substituted cyclic carbonyls and derivatives thereof useful as retrobiral protease inhibitors
EA200201279A1 (ru) Способы и композиции для лечения вирусного гепатита c
EA199901031A1 (ru) Производные бензимидазола
ATE219366T1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
MX9805441A (es) Compuestos terapeuticos.
PH27309A (en) Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones
UA37251C2 (uk) Лікарський засіб для лікування або профілактики вірусної інфекції гепатиту в і спосіб лікування вірусної інфекції гепатиту в
ATE383161T1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
FI965114A7 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
OA09507A (en) Compositions and methods for treating or preventing AIDS ARC and HIV infection
DK0393530T3 (da) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
EP1143981A4 (fr) Traitement et prevention d'infections par le vih et d'autres infections virales
ATE196424T1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях
DE3883754D1 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
CA2155129A1 (fr) Combinaisons d'inhibiteurs retroviraux
RU93055683A (ru) Ингибиторы вич-протеазы, способ их получения, их использование, композиция
RU93055680A (ru) Ингибиторы вич-протеазы, способ получения, их использование, композиция